Editorial
doi: 10.1001/jama.2012.6152.
Hemorrhagic complications associated with aspirin: an underestimated hazard in clinical practice?
- PMID: 22706838
- DOI: 10.1001/jama.2012.6152
Item in Clipboard
Editorial
Hemorrhagic complications associated with aspirin: an underestimated hazard in clinical practice?
JAMA.
.
No abstract available
Comment on
-
Association of aspirin use with major bleeding in patients with and without diabetes.JAMA. 2012 Jun 6;307(21):2286-94. doi: 10.1001/jama.2012.5034. JAMA. 2012. PMID: 22706834
Similar articles
-
Benefits and risks of aspirin use.JAMA. 2012 Sep 19;308(11):1089-90; author reply 1090. doi: 10.1001/2012.jama.10720. JAMA. 2012. PMID: 22990258 No abstract available.
-
Benefits and risks of aspirin use.JAMA. 2012 Sep 19;308(11):1088-9; author reply 1090. doi: 10.1001/2012.jama.10717. JAMA. 2012. PMID: 22990257 No abstract available.
-
Tighter aspirin control urged for patients with diabetes. Taking aspirin increases bleeding risk that is not always outweighed by the potential benefits for patients with low cardiovascular disease risk.Heart Advis. 2010 Aug;13(8):6. Heart Advis. 2010. PMID: 22792576 No abstract available.
-
[Acetylsalicylic acid and gastrointestinal hemorrhages: preferably a lower dosage].Ned Tijdschr Geneeskd. 1996 Nov 9;140(45):2219-23. Ned Tijdschr Geneeskd. 1996. PMID: 8984364 Review. Dutch. No abstract available.
-
Reversing the effects of antiplatelet agents in the setting of intracranial hemorrhage: a look at the literature.J Intensive Care Med. 2015 Jan;30(1):3-7. doi: 10.1177/0885066613487298. J Intensive Care Med. 2015. PMID: 25492811 Review.
Cited by
-
Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups.BMC Med. 2019 Nov 4;17(1):198. doi: 10.1186/s12916-019-1428-0. BMC Med. 2019. PMID: 31679516 Free PMC article.
-
A short-term risk-benefit analysis of occasional and regular use of low-dose aspirin in primary prevention of vascular diseases: a nationwide population-based study.BMJ Open. 2015 Jan 9;5(1):e006694. doi: 10.1136/bmjopen-2014-006694. BMJ Open. 2015. PMID: 25575876 Free PMC article.
-
Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease?J Gen Intern Med. 2015 Feb;30(2):155-60. doi: 10.1007/s11606-014-2985-8. J Gen Intern Med. 2015. PMID: 25092016 Free PMC article.
-
Interplay between genetic and clinical variables affecting platelet reactivity and cardiac adverse events in patients undergoing percutaneous coronary intervention.PLoS One. 2014 Jul 22;9(7):e102701. doi: 10.1371/journal.pone.0102701. eCollection 2014. PLoS One. 2014. PMID: 25051347 Free PMC article.
-
A short-term effect of low-dose aspirin on major hemorrhagic risks in primary prevention: a case-crossover design.PLoS One. 2014 May 30;9(5):e98326. doi: 10.1371/journal.pone.0098326. eCollection 2014. PLoS One. 2014. PMID: 24879431 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
